Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sramek

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Drug Intelligence & Clinical Pharmacy|April 1, 1987
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophreniaJ M Herrera, J J Sramek, J F Costa
The American Journal of Psychiatry|April 1, 1986
Neuroleptic dosage for Asians: a failure to replicateJ J Sramek, M A Sayles, G M Simpson
Expert Opinion on Investigational Drugs|April 3, 2001
The status of ongoing trials for mild cognitive impairmentJ J Sramek, A E Veroff, N R Cutler
Contemporary Clinical Trials Communications|October 27, 2025
Establishing a clinical trial site: A primer for aspiring principal investigatorsJohn J Sramek, Modesto S Carrillo, Neal R Cutler
Schizophrenia Research|July 1, 1988
Clozapine in refractory schizophrenia. Preliminary findingsJ M Herrera, J Costa, J Sramek, et al.
Archives of Neurology|September 1, 1993
Poor tolerability of MK-458N R Cutler, J J Sramek, G A Block
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
The Journal of Clinical Psychiatry|April 1, 1983
Effect of lithium on leukocytes: a two-year follow-upE H Pi, J J Sramek, G M Simpson
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Drug Intelligence & Clinical Pharmacy|April 1, 1987
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophreniaJ M Herrera, J J Sramek, J F Costa
The American Journal of Psychiatry|April 1, 1986
Neuroleptic dosage for Asians: a failure to replicateJ J Sramek, M A Sayles, G M Simpson
Expert Opinion on Investigational Drugs|April 3, 2001
The status of ongoing trials for mild cognitive impairmentJ J Sramek, A E Veroff, N R Cutler
Contemporary Clinical Trials Communications|October 27, 2025
Establishing a clinical trial site: A primer for aspiring principal investigatorsJohn J Sramek, Modesto S Carrillo, Neal R Cutler
Schizophrenia Research|July 1, 1988
Clozapine in refractory schizophrenia. Preliminary findingsJ M Herrera, J Costa, J Sramek, et al.
Archives of Neurology|September 1, 1993
Poor tolerability of MK-458N R Cutler, J J Sramek, G A Block
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
The Journal of Clinical Psychiatry|April 1, 1983
Effect of lithium on leukocytes: a two-year follow-upE H Pi, J J Sramek, G M Simpson
Pageof 16